(AFX UK Focus) 2010-06-12 02:42 UPDATE 2-U.S. panel probes marketing of Wyeth transplant drug
WASHINGTON, June 11 (Reuters) – A U.S. House of Representatives committee is investigating reports that drugmaker Wyeth, now a unit of Pfizer Inc, promoted a transplant drug to African-Americans for unapproved uses, the panel’s chairman said on Friday. The House Oversight and Government Reform Committee is probing if Wyeth encouraged Rapamune use for patients with heart, lung, liver, pancreas …

Read more on Interactive Investor

Related Blogs

• DALLAS HAIR TRANSPLANT DIARY: FEMALE HAIRLINE LOWERING PART1 …
• Balloon Juice » Blog Archive » Doggie Drama Update
• House committee investigating Wyeth over possible illegal …
• EUR/JPY Update | the evil speculator – one nefarious trade at a time
• Reuters: Credit raters could get reprieve in Wall St bill | Al …
• Update on Rights and Democracy Access-to-Information Request – The …
• Reuters Investment Summit (Media) | The Big Picture
• Today in Washington – June 15, 2010 | RedState
• Reuters Global Real Estate Summit Kicks Off This Week; Will Visit …
• US committee says gay blood ban will stay in place – from Pink …
• Red Shirts Advocate Peace Following Panel Appointment | Pattaya …
• BP: House Energy and Commerce Committee Chairmen Send Damning …
• House Panel Probes Marketing of Kidney Transplant Drug | FairWarning
• JUNE GLOOM: More Bad News For Tom Cruise & Cameron Diaz & Fox …
• JUNE GLOOM CONSUMES HOLLYWOOD: The Week That Studios Sought Out …
• OnLive Cloud Gaming Service goes live June 17
• (AFX UK Focus) 2010-06-14 16:09 Freddie Mac, FHLB, Fannie Mae 2010 …
• Next Generation of Droid Unleashed June 23rd | AndroidGuys
• Study: routine use of inexpensive drug could prevent 100000 …
• Flournoy, Petraeus Tell Senate Panel Afghan Training Mission Is …

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.